However, due to cancer heterogeneity, HCC patients suffered from quite different outcome after TACE, which indicated that hypoxia was not the only reason for aberrant overexpression of HIF-1α after TACE. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.